Session 10D: The new global biotech landscape: Opportunities beyond borders
Tracks
Track 4
| Friday, October 23, 2026 |
| 12:20 PM - 1:05 PM |
| Industry & Ecosystems Breakout Room |
Details
Global biotechnology is entering a new era. Innovation is no longer concentrated in a handful of traditional markets, with countries across Asia and other emerging regions reshaping drug discovery, clinical development, investment and commercialisation. As new centres of excellence emerge and global partnerships become increasingly important, Australian companies have unprecedented opportunities to expand their international reach.
In this fireside conversation, Brendan Shaw joins a leading global industry leader to explore the forces reshaping biotechnology worldwide, the opportunities arising from rapidly evolving markets—including China—and how Australian organisations can position themselves for long-term global success through collaboration, investment and strategic partnerships.
Speaker
Dr Liz Dallimore
CEO & Managing Director
Argenica Therapeutics Ltd
Panellist
Dr. Ye Yin
CEO
BGI Group
Panellist